Indeed, chromosomal copy number gains in both CDK8 and RB1 loci on 13q in colorectal cancer cells provide a clear explanation of how they select optimal conditions to antagonise E2F1 suppressions [127,130]. The gene discussed is CDK8; the disease is colorectal cancer.